Dr. Akhileshwar Namani, Ph.D
Dr. Namani's research focuses on the molecular mechanisms driving cancer, particularly the NRF2 signaling pathway, cancer omics, and therapeutic resistance.
Dr. Namani has expertise in Cancer genomics, Drug Discovery, Bioinformatics, and Computational Biology. He integrates multi-omics approaches and AI/ML driven models to identify biomarkers, therapeutic targets, and precision oncology strategies.
Education
- Ph.D (Biochemistry and Molecular Biology), Zhejiang University – School of Medicine (2013-2017).
- M.Sc (Biotechnology), Periyar University (2008-2010).
- B.Sc (Biotechnology, Zoology, and Chemistry), Kakatiya University (2005-2008).
Experience
- Scientist and Principal Investigator at Sri Shankara Cancer Hospital and Research Centre (Present).
- Assistant Professor at the Department of Biotechnology, GITAM Institute of Science, GITAM (Deemed to be) University (2020-2022).
- Post-Doctoral Fellow, Zhejiang University (2018-2019).
Honors and Awards
- Editorial Board Member - BMC Cancer, Discover Medicine, Discover Oncology
- Youth Editorial Board Member - Phenomics Journal
- International Scholarship provided by China Scholarship Council
- Third Prize for the Oral Presentation in 3rd International Conference for Cancer Metabolism and Treatment, Shanghai
- Best Research Presentation Award in the 3rd International Electronic Conference on Cancers (IECC2023)
- Member-European Society For Medical Oncology (ESMO ID: 685508)
- Member-International Association for the Study of Lung Cancer (IASLC ID: 551151)
